Carbon Dioxide Surgical Field Flooding and Aortic No-touch Off-pump Coronary Artery Bypass Grafting to Reduce Neurological Injuries After Surgical Coronary Revascularization (CANON): a Randomised, Controlled, Investigator and Patient Blinded Single Center Superiority Trial With Three Parallel Arms.

NACompletedINTERVENTIONAL
Enrollment

192

Participants

Timeline

Start Date

February 28, 2017

Primary Completion Date

July 1, 2018

Study Completion Date

July 1, 2018

Conditions
Neurological InjuryStrokePostoperative Cognitive DysfunctionPostoperative DeliriumCoronary Artery DiseaseCoronary Artery Bypass SurgeryOff-Pump Coronary Artery Bypass
Interventions
PROCEDURE

aortic no-touch OPCABG

(Study arm 1) In this intervention only the internal mammary artery grafts will be used (i.e. left internal mammary artery graft, right internal mammary artery graft, or a Y-graft that uses right internal mammary artery graft anastomosed onto left internal mammary artery graft to allow for a wide territory of myocardial revascularization). However, in the rare event that the aforementioned approach is insufficient to reach all target vessels, a reversed (great) saphenous vein graft may be used to extend the left internal mammary artery graft or the right internal mammary artery graft.

PROCEDURE

OPCABG with partial clamp applying carbon dioxide

(Study arm 2) In this intervention chest cavity will be insufflated with carbon dioxide at a flow above 5 l/min during the entire surgical procedure.

PROCEDURE

OPCABG with partial clamp

"(Study arm 3) This is the control arm undergoing traditional OPCABG with partial clamp."

Trial Locations (1)

85-001

Department of Cardiac Surgery, Dr Antoni Jurasz Memorial University Hospital, Bydgoszcz

All Listed Sponsors
lead

Collegium Medicum w Bydgoszczy

OTHER

NCT03074604 - Carbon Dioxide Surgical Field Flooding and Aortic No-touch Off-pump Coronary Artery Bypass Grafting to Reduce Neurological Injuries After Surgical Coronary Revascularization (CANON): a Randomised, Controlled, Investigator and Patient Blinded Single Center Superiority Trial With Three Parallel Arms. | Biotech Hunter | Biotech Hunter